These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

881 related items for PubMed ID: 15897171

  • 1. Treatment of hidradenitis suppurativa with infliximab in a patient with Crohn's disease.
    Rosi YL, Lowe L, Kang S.
    J Dermatolog Treat; 2005 Feb; 16(1):58-61. PubMed ID: 15897171
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Long-term efficacy of a single course of infliximab in hidradenitis suppurativa.
    Mekkes JR, Bos JD.
    Br J Dermatol; 2008 Feb; 158(2):370-4. PubMed ID: 18047504
    [Abstract] [Full Text] [Related]

  • 5. Hidradenitis suppurativa and Crohn's disease: two cases that support an association.
    Yazdanyar S, Miller IM, Jemec GB.
    Acta Dermatovenerol Alp Pannonica Adriat; 2010 Oct; 19(3):23-5. PubMed ID: 20976417
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Experiences with a long-term treatment of a massive gluteal acne inversa with infliximab in Crohn's disease.
    Goertz RS, Konturek PC, Naegel A, Janka R, Amann K, Maennlein G, Wein A, Hahn EG, Boxberger F.
    Med Sci Monit; 2009 Jan; 15(1):CS14-8. PubMed ID: 19114971
    [Abstract] [Full Text] [Related]

  • 8. Etanercept: effective in the management of hidradenitis suppurativa.
    Cusack C, Buckley C.
    Br J Dermatol; 2006 Apr; 154(4):726-9. PubMed ID: 16536817
    [Abstract] [Full Text] [Related]

  • 9. Hidradenitis suppurativa responding to treatment with infliximab.
    Lasocki A, Sinclair R, Foley P, Saunders H.
    Australas J Dermatol; 2010 Aug; 51(3):186-90. PubMed ID: 20695857
    [Abstract] [Full Text] [Related]

  • 10. A case of hidradenitis suppurativa refractory to anti-TNFalpha therapy in a patient with Crohn's disease.
    Koilakou S, Karapiperis D, Tzathas C.
    Am J Gastroenterol; 2010 Jan; 105(1):231-2. PubMed ID: 20054324
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Infliximab for the treatment of hidradenitis suppurativa.
    Fernández-Vozmediano JM, Armario-Hita JC.
    Dermatology; 2007 Jan; 215(1):41-4. PubMed ID: 17587838
    [Abstract] [Full Text] [Related]

  • 13. Infliximab for treatment of pyoderma gangrenosum associated with clinically inactive Crohn's disease. A case report.
    Kouklakis G, Moschos J, Leontiadis GI, Kadis S, Mpoumponaris A, Molyvas E, Minopoulos GI.
    Rom J Gastroenterol; 2005 Dec; 14(4):401-3. PubMed ID: 16400359
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Long-term infliximab for severe hidradenitis suppurativa.
    Thielen AM, Barde C, Saurat JH.
    Br J Dermatol; 2006 Nov; 155(5):1105-7. PubMed ID: 17034567
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Acne inversa treated with infliximab: different outcomes in 2 patients.
    Antonucci A, Negosanti M, Negosanti L, Iozzo I, Varotti C.
    Acta Derm Venereol; 2008 Nov; 88(3):274-5. PubMed ID: 18480930
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.